This is a type of anemia that babies are born with. It's a condition where the body doesn't make enough healthy red blood cells, and these cells break down too quickly. It's not caused by abnormal red blood cell shapes (like spherocytosis). The problem is usually a missing or faulty enzyme that helps red blood cells make energy.
Every report comes from a Lived member, sent anonymously.
Have you had Blood Transfusion for Congenital Nonspherocytic Hemolytic Anemia?
Congenital nonspherocytic hemolytic anemia is a group of inherited conditions in which red blood cells break down sooner than they should. Hemolytic means red cells are being destroyed; anemia means there are too few of them to carry enough oxygen around the body. Nonspherocytic separates this group from hereditary spherocytosis, in which red cells become small and round: here the cells keep a largely normal shape, and the hemoglobin inside them is normal too. The usual problem is a faulty enzyme inside the red cell. Unlike most cells, red cells cannot use oxygen to make energy, so they depend on a chain of enzymes that break down glucose (glycolysis), along with related enzymes that protect them from chemical damage. When one of these enzymes works poorly, the cells run short of energy and are cleared early, mostly by the spleen. Pyruvate kinase (PK) deficiency is by far the most common cause. Rarer causes include glucose phosphate isomerase (GPI) deficiency, triosephosphate isomerase (TPI) deficiency and a small number of uncommon forms of G6PD (glucose-6-phosphate dehydrogenase) deficiency. Because red cells are destroyed continuously, people may have pale skin, yellowing of the skin and eyes (jaundice), fatigue, shortness of breath with effort, a fast heartbeat and an enlarged spleen. Severity varies enormously, even among people with the same cause. Some have few or no symptoms and are diagnosed by chance, while others are severely affected before birth and need regular blood transfusions throughout life.
These conditions are inherited, so they are present from birth and are not caused by anything a person or their parents did. PK deficiency and GPI deficiency are autosomal recessive: a child is affected when they inherit a nonworking copy of the gene from each parent. Parents who carry a single copy usually have no symptoms. G6PD deficiency is X-linked, so it affects males more often. PK deficiency occurs worldwide and is more common in some communities, such as the Old Order Amish of Pennsylvania. The specific gene changes a person carries help explain why severity differs so much, and in PK deficiency they also affect which treatments are likely to work. Although the underlying anemia is constant, some situations make red cell breakdown worse for a time. Infections and pregnancy can deepen anemia in PK deficiency, and infections can set off hemolytic crises in GPI deficiency. In the rare chronic forms of G6PD deficiency, the triggers known from the common form of G6PD deficiency, such as certain medicines, fava beans and infection, can add sudden episodes of more severe breakdown.
Diagnosis usually starts with a complete blood count showing anemia, along with tests showing that red cells are being destroyed and replaced quickly. These include a high reticulocyte count (young red cells the bone marrow releases to compensate), raised bilirubin (the yellow pigment that causes jaundice) and lactate dehydrogenase (LDH, released from broken cells), and low haptoglobin (a protein used up when red cells break apart). A blood smear viewed under the microscope and tests for abnormal hemoglobin help rule out hereditary spherocytosis, sickle cell disease and thalassemia, and other tests check that the immune system is not attacking the red cells. Once those causes are excluded, specialized tests measure the activity of individual red cell enzymes, such as PK or G6PD. These results can be misleading after a recent transfusion, because donated cells carry normal enzyme levels. Genetic testing, often a panel that checks many hereditary anemia genes at once, is not affected by transfusion and can confirm the exact cause. In PK deficiency, knowing the specific gene changes also helps predict whether the targeted medicine mitapivat is likely to work. In newborns, severe jaundice or anemia that needs light therapy (phototherapy) or a transfusion is often the first sign.
Treatment depends on the cause, how severe the anemia is and the person's age. Much of care is supportive: it aims to keep energy and growth as normal as possible while preventing the long-term effects of constant red cell breakdown. Red blood cell transfusions are used when anemia causes symptoms, during infancy and early childhood, and during sudden drops. Some people need them only occasionally; others need them on a regular schedule. Folic acid supplements are commonly given because the bone marrow uses extra folate as it keeps replacing destroyed cells. Newborns with severe jaundice may need phototherapy or an exchange transfusion, in which much of the baby's blood is gradually replaced. Removing the spleen (splenectomy) reduces red cell destruction in many people with PK deficiency. In a large international registry it raised hemoglobin by a median of 1.6 g/dL and lowered transfusion needs in most people who had it, although it does not cure the anemia. Young children are often managed with transfusions until they are older. The trade-offs last for life: people without a spleen are more vulnerable to serious bacterial infections, so they need specific vaccines and sometimes preventive antibiotics, and about 1 in 10 people in that registry developed blood clots afterward. Because gallstones are common, the gallbladder is often removed at the same time or later. Mitapivat (Pyrukynd) is a tablet that activates the pyruvate kinase enzyme so red cells can make more energy. In the US it is approved for adults with PK deficiency, not for children or for other enzyme defects. In a placebo-controlled trial of adults who were not regularly transfused, 40% had a meaningful rise in hemoglobin (at least 1.5 g/dL), compared with none on placebo. Among regularly transfused adults, some needed fewer transfusions and about 1 in 5 needed none during the study period. It works mainly in people with at least one missense variant (a gene change that alters a single building block of the enzyme) and rarely helps people with two more disruptive variants. People with two copies of the variant common in the Amish community also tend to respond poorly. It should not be stopped suddenly, because red cell breakdown can rebound sharply, and liver blood tests are checked during the first months. Iron builds up in many people, from transfusions and even in those who are rarely transfused, so iron chelation medicines that remove excess iron are often needed. For severe, transfusion-dependent disease, a stem cell (bone marrow) transplant can replace the faulty red cell production, but it carries serious risks, including graft-versus-host disease and death, so it is considered only for selected people.
These are lifelong conditions, but daily life varies widely. Many people with mild or moderate anemia go to school, work and exercise, though fatigue and reduced stamina are common and can come and go. People who need regular transfusions have a more structured routine of infusion visits and monitoring. Complications build up from years of red cell breakdown and from treatment, and they can appear even when hemoglobin seems stable. In a large registry of people with PK deficiency, iron overload and gallstones each affected nearly half, and others included thinning bones, pulmonary hypertension (high blood pressure in the lungs), leg ulcers, and masses of blood-forming tissue outside the bone marrow. Regular follow-up with a hematologist (a blood specialist) usually includes blood counts, iron levels, and checks for gallstones and bone health, whatever the hemoglobin level. Anemia can deepen during infections and pregnancy, and occasionally the bone marrow briefly stops making new red cells (an aplastic crisis), causing a rapid fall in blood counts. Pregnancy is best planned with both the hematology and obstetric teams. Because these conditions are inherited, relatives and future children may benefit from genetic counseling. The rarer enzyme defects can affect more than the blood. A small number of people with GPI deficiency have learning or coordination problems, and TPI deficiency causes progressive nerve and muscle problems and frequent infections, and is often fatal in childhood.
Ask about an evaluation for inherited hemolytic anemia if you or your child has unexplained anemia with jaundice, an enlarged spleen or gallstones at a young age, or a family history of hemolytic anemia. People already diagnosed need regular hematology follow-up even when they feel well. Contact the care team right away for signs that anemia is worsening quickly: deeper yellowing of the skin or eyes, dark urine, unusual paleness or tiredness, dizziness or confusion, or shortness of breath. This matters especially during an infection or after missing or stopping doses of mitapivat. For anyone whose spleen has been removed, a fever or chills needs medical care within hours, because infections can become life-threatening quickly without a spleen. Take any emergency antibiotic the care team has prescribed and get seen urgently, going to an emergency department if the care team cannot be reached promptly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Congenital Nonspherocytic Hemolytic Anemia is like, what's helped you, or ask the community a question.